PROJECT

Projects

Summary of Investment Information

Project Number

39247

Company Name

NOBEL ILAC SANAYII VE TICARET A.S.

Date SPI Disclosed

Mar 21, 2017

Country

Turkiye

Region

Central Asia and Turkiye

Projected Board Date

Apr 23, 2017

Environmental Category

B - Limited

Status

Active

Last Updated Date

Nov 2, 2017

Department

Regional Industry - MAS ECA

Industry

Health, Education and Life Sciences

Previous Events

Approved : Jul 27, 2017
Signed : Jul 31, 2017
Invested : Oct 31, 2017

Sector

Pharmaceuticals and Medicine

Project Description

Nobel Ilac ("Nobel") is a Turkish generic pharmaceuticals company that produces, markets, distributes and sells products domestically and exports across Europe and Central Asia. Its product portfolio is spread across chronic, acute and consumer health therapeutic areas. Nobel’s investment plan of US$44.5 million encompasses its expansion into two new subsectors: (i) Biotechnology R&D and production, and (ii) the production of injectable form drugs,  in addition to developing a high bay warehouse to optimize supply chain and inventory management.

 

Sponsor / Cost / Location

Development Impact

E&S Category Rationale / Risks and Mitigation